Key facts
- Notable investors include Beijing State-owned Capital Operation and Management, YuanBio Venture Capital, Shun Xi Fund, Chongqing Zhifei Biological Products Company, Renhe Capital — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for GuanQiao
- ·The full record, as it builds
Funding rounds
No funding rounds for GuanQiao are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GuanQiao
Manufacturer of advanced medical devices intended to treat pulmonary embolism, venous thrombosis, and intracranial stenosis. The company offers thrombus clearance systems and aspiration catheters, enabling hospitals and healthcare providers to improve patient outcomes in vascular and respiratory care.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2020
- Ownership
- Privately Held (backing)
GuanQiao doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GuanQiao shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GuanQiao in its N-PORT filings yet. We sweep new filings monthly.